110 related articles for article (PubMed ID: 7605933)
1. 5-HT efflux from rat hippocampus in vivo produced by 4-aminopyridine is increased by chronic lithium administration.
Pei Q; Leslie RA; Grahame-Smith DG; Zetterström TS
Neuroreport; 1995 Mar; 6(5):716-20. PubMed ID: 7605933
[TBL] [Abstract][Full Text] [Related]
2. The potassium channel blockers 4-aminopyridine and tetraethylammonium increase the spontaneous basal release of [3H]5-hydroxytryptamine in rat hippocampal slices.
Schechter LE
J Pharmacol Exp Ther; 1997 Jul; 282(1):262-70. PubMed ID: 9223563
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of potassium channel blockers on extracellular concentrations of dopamine and 5-HT in the striatum of conscious rats.
Dawson LA; Routledge C
Br J Pharmacol; 1995 Dec; 116(8):3260-4. PubMed ID: 8719805
[TBL] [Abstract][Full Text] [Related]
4. Effect of short- and long-term administration of lithium on the release of endogenous 5-HT in the hippocampus of the rat in vivo and in vitro.
Sharp T; Bramwell SR; Lambert P; Grahame-Smith DG
Neuropharmacology; 1991 Sep; 30(9):977-84. PubMed ID: 1922695
[TBL] [Abstract][Full Text] [Related]
5. Effects of acute and chronic buspirone on impulsive choice and efflux of 5-HT and dopamine in hippocampus, nucleus accumbens and prefrontal cortex.
Liu YP; Wilkinson LS; Robbins TW
Psychopharmacology (Berl); 2004 Apr; 173(1-2):175-85. PubMed ID: 14726995
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of potassium channel blockers on dopamine release from rat striatal slices.
Boireau A; Richard F; Olivier V; Aubeneau M; Miquet JM; Dubédat P; Laduron P; Doble A; Blanchard JC
J Pharm Pharmacol; 1991 Nov; 43(11):798-801. PubMed ID: 1686910
[TBL] [Abstract][Full Text] [Related]
7. Potassium channel blockers inhibit D2 dopamine, but not A1 adenosine, receptor-mediated inhibition of striatal dopamine release.
Cass WA; Zahniser NR
J Neurochem; 1991 Jul; 57(1):147-52. PubMed ID: 1828829
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of four dendrotoxin peptides, 4-aminopyridine and tetraethylammonium on the electrically evoked [3H]noradrenaline release from rat hippocampus.
Hu PS; Benishin C; Fredholm BB
Eur J Pharmacol; 1991 Dec; 209(1-2):87-93. PubMed ID: 1687682
[TBL] [Abstract][Full Text] [Related]
9. Neurochemical effects of chronic haloperidol and lithium assessed by brain microdialysis in rats.
Hernandez L; Baptista T; Hoebel BG
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14 Suppl():S17-35. PubMed ID: 2097671
[TBL] [Abstract][Full Text] [Related]
10. Selective stimulation of serotonin2c receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration.
Di Matteo V; Pierucci M; Esposito E
J Neurochem; 2004 Apr; 89(2):418-29. PubMed ID: 15056285
[TBL] [Abstract][Full Text] [Related]
11. Possible involvement of presynaptic 5-HT autoreceptors in effect of lithium on 5-HT release in hippocampus of rat.
Hotta I; Yamawaki S
Neuropharmacology; 1988 Oct; 27(10):987-92. PubMed ID: 3237318
[TBL] [Abstract][Full Text] [Related]
12. Quinine and 4-aminopyridine inhibit the stimulatory output of dopamine in nucleus accumbens and the behavioural activity produced by morphine.
Pei Q; Elliott JM; Grahame-Smith DG; Zetterström T
Eur J Pharmacol; 1993 Nov; 249(2):243-6. PubMed ID: 8287908
[TBL] [Abstract][Full Text] [Related]
13. An intact dopaminergic system is required for context-conditioned release of 5-HT in the nucleus accumbens of postweaning isolation-reared rats.
Fulford AJ; Marsden CA
Neuroscience; 2007 Oct; 149(2):392-400. PubMed ID: 17869434
[TBL] [Abstract][Full Text] [Related]
14. Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats.
O'Shea E; Escobedo I; Orio L; Sanchez V; Navarro M; Green AR; Colado MI
Neuropsychopharmacology; 2005 Jul; 30(7):1312-23. PubMed ID: 15688085
[TBL] [Abstract][Full Text] [Related]
15. Restricted usefulness of tetraethylammonium and 4-aminopyridine for the characterization of receptor-operated K+-channels.
Drukarch B; Kits KS; Leysen JE; Schepens E; Stoof JC
Br J Pharmacol; 1989 Sep; 98(1):113-8. PubMed ID: 2553183
[TBL] [Abstract][Full Text] [Related]
16. Effects of lithium treatment on extracellular serotonin levels in the dorsal hippocampus and wet-dog shakes in the rat.
Mørk A
Eur Neuropsychopharmacol; 1998 Dec; 8(4):267-72. PubMed ID: 9928915
[TBL] [Abstract][Full Text] [Related]
17. [3H]dopamine and [3H]serotonin release in vitro induced by electrical stimulation in A9 and A10 dopamine regions of rat brain: characterization and responsiveness to cocaine.
Chen NH; Reith ME
J Pharmacol Exp Ther; 1993 Oct; 267(1):379-89. PubMed ID: 8229765
[TBL] [Abstract][Full Text] [Related]
18. In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum.
Navailles S; De Deurwaerdère P; Porras G; Spampinato U
Neuropsychopharmacology; 2004 Feb; 29(2):319-26. PubMed ID: 14560323
[TBL] [Abstract][Full Text] [Related]
19. Opiate modulation of striatal dopamine and hippocampal norepinephrine release following morphine withdrawal.
Grasing K; Bills D; Ghosh S; Schlussman SD; Patel AH; Woodward JJ
Neurochem Res; 1997 Mar; 22(3):239-48. PubMed ID: 9051656
[TBL] [Abstract][Full Text] [Related]
20. Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism.
Huang M; Panos JJ; Kwon S; Oyamada Y; Rajagopal L; Meltzer HY
J Neurochem; 2014 Mar; 128(6):938-49. PubMed ID: 24164459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
